Meet with us at
June 5 - 8, 2023
BIO International Convention brings together leading innovators across the biotech industry for four days of top tier programming in Boston this June. With over 14,000 attendees from every corner of the industry and the globe, this event is your chance to make invaluable connections with biotech and pharma professionals, get inspired by global thought leaders, and increase your company’s visibility on an international scale.
Stop by Curia's Booth #3565
Dr. Christine L. Hsieh joined Curia from LakePharma, the Biologics Company in 2020. She is a Senior Research Scientist within Curia’s Antibody Discovery, Engineering, and Characterization group at San Carlos, California. Her team of experts are dedicated to partnering with clients for Antibody Discovery and Gene to Protein services. Christine currently leads the Single B Cell Antibody Discovery team, she specializes in cellular immunology assay development, and she serves as a subject matter expert in client discussions.
Christine is a trained immunologist interested in immunology-based disease mechanisms and therapies. She joined LakePharma to support Hybridoma and Phage/Yeast Display technologies to support the biotechnology industry to realize treatments. At Curia, she led efforts to establish a new platform and leads the Single B Cell Antibody Discovery group using state-of-the-art technologies to expedite antibody discovery. Other career highlights for Christine include that she is an Associate Professor in Rheumatology at the University of California, San Francisco. She is also the Director of the Flow Cytometry Core, Molecular Biology Core, and Cell Imaging Core Facilities at the San Francisco VA Medical Center.
Christine earned her Bachelor of Science in Molecular, Cell, and Developmental Biology from the University of California, Los Angeles. She received her Ph.D. in Immunology from Stanford University, and performed her Postdoctoral Fellowship in Neuroimmunology at the University of California, San Francisco. She has authored several peer-reviewed publications and is the proud recipient of Curia’s Research & Development Innovation Award of 2023.
Scott Alderucci is the director of process development overseeing the process development and GMP divisions of mRNA at Curia. He holds a scientific master’s degree and has 25 years of experience working in the field of biologics focused on DNA, mRNA and antibody platforms. He has worked within such institutions as Millennium Pharmaceuticals, Cellular Genomics, the State of Massachusetts, and Shire Pharmaceuticals prior to joining Curia. His current role is focused on providing research and development through GMP level production of a wide range of mRNA products to meet various program goals.
Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 29 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics.
To learn more visit us at curiaglobal.com
415 Summer St, Boston, MA 02210
Be the conduit that connects ideas to solutions. Contribute to the creation and distribution of treatments that enhance and save lives. Ensure that medicines are more accessible and help breakthroughs break through faster. The impact is real at Curia (formerly Albany Molecular Research, Inc.), and you can help us take it to even greater heights.
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We’ve got it down to an exact science.